Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Preferred Stock Liabilities: 2017-2019

Historic Preferred Stock Liabilities for Outlook Therapeutics (OTLK) over the last 3 years, with Sep 2019 value amounting to $5.4 million.

  • Outlook Therapeutics' Preferred Stock Liabilities rose 28.34% to $6.5 million in Q1 2020 from the same period last year, while for Mar 2020 it was $6.5 million, marking a year-over-year increase of 28.34%. This contributed to the annual value of $5.4 million for FY2019, which is 13.20% up from last year.
  • Outlook Therapeutics' Preferred Stock Liabilities amounted to $5.4 million in FY2019, which was up 13.20% from $4.7 million recorded in FY2018.
  • In the past 5 years, Outlook Therapeutics' Preferred Stock Liabilities registered a high of $5.4 million during FY2019, and its lowest value of $2.9 million during FY2017.
  • Its 3-year average for Preferred Stock Liabilities is $4.3 million, with a median of $4.7 million in 2018.
  • Data for Outlook Therapeutics' Preferred Stock Liabilities shows a peak YoY spiked of 61.89% (in 2018) over the last 5 years.
  • Yearly analysis of 3 years shows Outlook Therapeutics' Preferred Stock Liabilities stood at $2.9 million in 2017, then surged by 61.89% to $4.7 million in 2018, then grew by 13.20% to $5.4 million in 2019.